Email Alert RSS
Volume 12 Issue 6
Nov.  2021
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555
Citation: Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 902-912. DOI: 10.12290/xhyxzz.2021-0555
shu

Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)

Funds: 

National Key Research and Development Program of China 2016YFC0901500

Capital's Funds for Health Improvement and Research 2020-2-4018

Beijing Natural Science Foundation L202035

CAMS Innovation Fund for Medical Sciences 2020-I2M-C & T-A-001

CAMS Innovation Fund for Medical Sciences 2021-1-I2M-003

More Information

  • Corresponding authors: CHEN Limeng1, 3, E-mail: chenlimeng@pumch.cn ZHANG Shuyang2, 3, E-mail: shuyangzhang103@163.com.
    1. Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
    2. Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
    3. State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • Received Date: July 25, 2021
  • Accepted Date: August 03, 2021
  • Available Online: October 14, 2021
  • Issue Publish Date: November 29, 2021
    Graphical Abstract
    • Abstract
  • In recent years, research on the clinical phenotypes, new classifications, modified functional tests, biomarkers and management experience for patients with Gitelman syndrome (GS)has made a lot of progress in China. Based on evidence-based medicine, this consensus summarizes aspects related to GS, including clinical manifestations and classification, diagnosis, treatment strategies, and management of chronic complications and comorbidity. This consensus provides an important reference for the diagnosis and treatment of GS.
    • FullText(HTML)
    • References (77)
  • [1]
    Blanchard A, Bockenhauer D, Bolignano D, et al. Gitel-man syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Contro-versies Conference[J]. Kidney Int, 2017, 91: 24-33. DOI: 10.1016/j.kint.2016.09.046
    [2]
    Gitelman综合征诊治专家共识协作组. Gitelman综合征诊治专家共识[J]. 中华内科杂志, 2017, 56: 712-716. DOI: 10.3760/cma.j.issn.0578-1426.2017.09.021
    [3]
    Graham AJ, Gelfand G, McFadden SD, et al. Levels of evidence and grades of recommendations in general thoracic surgery[J]. Can J Surg, 2004, 47: 461-465. http://europepmc.org/articles/PMC3211591/pdf/20041200s00014p461.pdf
    [4]
    中华医学会内科学分会, 王建祥, 张奉春, 等. 中国成人血小板减少症诊疗专家共识[J]. 中华内科杂志, 2020, 59: 498-510. DOI: 10.3760/cma.j.cn112138-20200424-00419
    [5]
    Jones J, Hunter D. Consensus methods for medical and health services research[J]. BMJ, 1995, 311: 376-380. DOI: 10.1136/bmj.311.7001.376
    [6]
    Zhang L, Peng X, Zhao B, et al. Clinical and laboratory features of female Gitelman syndrome and the pregnancy outcomes in a Chinese cohort[J]. Nephrology (Carlton), 2020, 25: 749-757. DOI: 10.1111/nep.13743
    [7]
    Tseng MH, Yang SS, Hsu YJ, et al. Genotype, pheno-type, and follow-up in Taiwanese patients with salt-losing tubulopathy associated with SLC12A3 mutation[J]. J Clin Endocrinol Metab, 2012, 97: E1478-E1482. DOI: 10.1210/jc.2012-1707
    [8]
    Bulucu F, Vural A, Yenicesu M, et al. Association of Gitelman's syndrome and focal glomerulosclerosis[J]. Nephron, 1998, 79: 244. DOI: 10.1159/000045043
    [9]
    Rosado Rubio C, Fraile Gómez P, Gómez Muñoz MA, et al. C1q nephropathy in a patient with Gitelman syndrome[J]. NDT Plus, 2011, 4: 392-393. http://www.scienceopen.com/document_file/d68aa916-441e-4561-92f5-54f3b8a8b0af/PubMedCentral/d68aa916-441e-4561-92f5-54f3b8a8b0af.pdf
    [10]
    Hanevold C, Mian A, Dalton R. C1q nephropathy in association with Gitelman syndrome: a case report[J]. Pediatr Nephrol, 2006, 21: 1904-1908. DOI: 10.1007/s00467-006-0261-9
    [11]
    Chen Q, Wu Y, Zhao J, et al. A case of hypokalemia and proteinuria with a new mutation in the SLC12A3 Gene[J]. BMC Nephrol, 2018, 19: 275. DOI: 10.1186/s12882-018-1083-2
    [12]
    Konrad M, Nijenhuis T, Ariceta G, et al. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders[J]. Kidney Int, 2021, 99: 324-335. DOI: 10.1016/j.kint.2020.10.035
    [13]
    Shao L, Ren H, Wang W, et al. Novel SLC12A3 muta-tions in Chinese patients with Gitelman's syndrome[J]. Nephron Physiol, 2008, 108: 29-36. DOI: 10.1159/000117815
    [14]
    Qin L, Shao L, Ren H, et al. Identification of five novel variants in the thiazide-sensitive NaCl co-transporter gene in Chinese patients with Gitelman syndrome[J]. Nephrology (Carlton), 2009, 14: 52-58. DOI: 10.1111/j.1440-1797.2008.01042.x
    [15]
    Miao M, Zhao CQ, Wang XL, et al. Clinical and genetic analyses of Chinese patients with Gitelman syndrome[J]. Genet Mol Res, 2016. doi: 10.4238/gmr.15027859.
    [16]
    Wang F, Shi C, Cui Y, et al. Mutation profile and treatment of Gitelman syndrome in Chinese patients[J]. Clin Exp Nephrol, 2017, 21: 293-299. DOI: 10.1007/s10157-016-1284-6
    [17]
    Liu T, Wang C, Lu J, et al. Genotype/phenotype analysis in 67 Chinese patients with Gitelman's syndrome[J]. Am J Nephrol, 2016, 44: 159-168. DOI: 10.1159/000448694
    [18]
    Ma J, Ren H, Lin L, et al. Genetic features of Chinese patients with Gitelman syndrome: sixteen novel SLC12A3 mutations identified in a new cohort[J]. Am J Nephrol, 2016, 44: 113-121. DOI: 10.1159/000447366
    [19]
    Zeng Y, Li P, Fang S, et al. Genetic analysis of SLC12A3 gene in Chinese patients with Gitelman syndrome[J]. Med Sci Monit, 2019, 25: 5942-5952. DOI: 10.12659/MSM.916069
    [20]
    Vargas-Poussou R, Dahan K, Kahila D, et al. Spectrum of mutations in Gitelman syndrome[J]. J Am Soc Nephrol, 2011, 22: 693-703. DOI: 10.1681/ASN.2010090907
    [21]
    Glaudemans B, Yntema HG, San-Cristobal P, et al. Novel NCC mutants and functional analysis in a new cohort of patients with Gitelman syndrome[J]. Eur J Hum Genet, 2012, 20: 263-270. DOI: 10.1038/ejhg.2011.189
    [22]
    Peng X, Zhao B, Zhang L, et al. Hydrochlorothiazide test as a tool in the diagnosis of Gitelman syndrome in Chinese patients[J]. Front Endocrinol (Lausanne), 2018, 9: 559. DOI: 10.3389/fendo.2018.00559
    [23]
    Nozu K, Iijima K, Nozu Y, et al. A deep intronic mutation in the SLC12A3 gene leads to Gitelman syndrome[J]. Pediatr Res, 2009, 66: 590-593. DOI: 10.1203/PDR.0b013e3181b9b4d3
    [24]
    Nozu K, Nozu Y, Nakanishi K, et al. Cryptic exon activation in SLC12A3 in Gitelman syndrome[J]. J Hum Genet, 2017, 62: 335-337. DOI: 10.1038/jhg.2016.129
    [25]
    Lo YF, Nozu K, Iijima K, et al. Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome[J]. Clin J Am Soc Nephrol, 2011, 6: 630-639. DOI: 10.2215/CJN.06730810
    [26]
    Nagano C, Nozu K, Morisada N, et al. Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases[J]. Clin Exp Nephrol, 2018, 22: 881-888. DOI: 10.1007/s10157-018-1534-x
    [27]
    Tavira B, Gómez J, Santos F, et al. A labor- and cost-effective non-optical semiconductor (Ion Torrent) next-generation sequencing of the SLC12A3 and CLCNKA/B genes in Gitelman's syndrome patients[J]. J Hum Genet, 2014, 59: 376-380. DOI: 10.1038/jhg.2014.37
    [28]
    Ashton EJ, Legrand A, Benoit V, et al. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies[J]. Kidney Int, 2018, 93: 961-967. DOI: 10.1016/j.kint.2017.10.016
    [29]
    Hureaux M, Ashton E, Dahan K, et al. High-throughput sequencing contributes to the diagnosis of tubulopathies and familial hypercalcemia hypocalciuria in adults[J]. Kidney Int, 2019, 96: 1408-1416. DOI: 10.1016/j.kint.2019.08.027
    [30]
    Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17: 405-424. DOI: 10.1038/gim.2015.30
    [31]
    Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome[J]. J Am Soc Nephrol, 2007, 18: 1271-1283. DOI: 10.1681/ASN.2006101095
    [32]
    De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, et al. Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome[J]. J Am Soc Nephrol, 2002, 13: 1442-1448. DOI: 10.1097/01.ASN.0000017904.77985.03
    [33]
    Kunchaparty S, Palcso M, Berkman J, et al. Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome[J]. Am J Physiol, 1999, 277: F643-F649. http://www.researchgate.net/profile/Gary_Desir/publication/12784778_Defective_processing_and_expression_of_the_thiazide-sensitive_Na-Cl_cotransporter_as_a_cause_Gitelman%27s_Syndrome/links/554390a00cf234bdb21bd1ce.pdf
    [34]
    Sabath E, Meade P, Berkman J, et al. Pathophysiology of functional mutations of the thiazide-sensitive Na-Cl cotransporter in Gitelman disease[J]. Am J Physiol Renal Physiol, 2004, 287: F195-F203. DOI: 10.1152/ajprenal.00044.2004
    [35]
    Colussi G, Bettinelli A, Tedeschi S, et al. A thiazide test for the diagnosis of renal tubular hypokalemic disorders[J]. Clin J Am Soc Nephrol, 2007, 2: 454-460. DOI: 10.2215/CJN.02950906
    [36]
    彭晓艳, 蒋兰萍, 袁涛, 等. 氯离子清除试验在Gitelman综合征鉴别诊断中的应用[J]. 中国医学科学院学报, 2016, 38: 275-282. DOI: 10.3881/j.issn.1000-503X.2016.03.006
    [37]
    Nozu K, Iijima K, Kanda K, et al. The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies[J]. J Clin Endocrinol Metab, 2010, 95: E511-E518. DOI: 10.1210/jc.2010-0392
    [38]
    张军, 陈秋莉, 李燕虹, 等. 呋塞米/氢氯噻嗪负荷试验在儿童Bartter综合征和Gitelman综合征鉴别诊断中的应用[J]. 临床儿科杂志, 2016, 34: 891-893. DOI: 10.3969/j.issn.1000-3606.2016.12.003
    [39]
    Lin SH, Cheng NL, Hsu YJ, et al. Intrafamilial pheno-type variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotrans-porter[J]. Am J Kidney Dis, 2004, 43: 304-312. DOI: 10.1053/j.ajkd.2003.10.018
    [40]
    Fukuyama S, Okudaira S, Yamazato S, et al. Analysis of renal tubular electrolyte transporter genes in seven patients with hypokalemic metabolic alkalosis[J]. Kidney Int, 2003, 64: 808-816. DOI: 10.1046/j.1523-1755.2003.00163.x
    [41]
    Lin SH, Shiang JC, Huang CC, et al. Phenotype and genotype analysis in Chinese patients with Gitelman's syndrome[J]. J Clin Endocrinol Metab, 2005, 90: 2500-2507. DOI: 10.1210/jc.2004-1905
    [42]
    Berry MR, Robinson C, Karet Frankl FE. Unexpected clinical sequelae of Gitelman syndrome: hypertension in adulthood is common and females have higher potassium requirements[J]. Nephrol Dial Transplant, 2013, 28: 1533-1542. DOI: 10.1093/ndt/gfs600
    [43]
    Cruz DN, Shaer AJ, Bia MJ, et al. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life[J]. Kidney Int, 2001, 59: 710-717. DOI: 10.1046/j.1523-1755.2001.059002710.x
    [44]
    Tammaro F, Bettinelli A, Cattarelli D, et al. Early appearance of hypokalemia in Gitelman syndrome[J]. Pediatr Nephrol, 2010, 25: 2179-2182. DOI: 10.1007/s00467-010-1575-1
    [45]
    Jiang L, Chen C, Yuan T, et al. Clinical severity of Gitelman syndrome determined by serum magnesium[J]. Am J Nephrol, 2014, 39: 357-366. DOI: 10.1159/000360773
    [46]
    Larkins N, Wallis M, McGillivray B, et al. A severe phenotype of Gitelman syndrome with increased prostaglandin excretion and favorable response to indomethacin[J]. Clin Kidney J, 2014, 7: 306-310. DOI: 10.1093/ckj/sfu029
    [47]
    Jeck N, Schlingmann KP, Reinalter SC, et al. Salt handl-ing in the distal nephron: lessons learned from inherited human disorders[J]. Am J Physiol Regul Integr Comp Physiol, 2005, 288: R782-R795. DOI: 10.1152/ajpregu.00600.2004
    [48]
    Liaw LC, Banerjee K, Coulthard MG. Dose related growth response to indometacin in Gitelman syndrome[J]. Arch Dis Child, 1999, 81: 508-510. DOI: 10.1136/adc.81.6.508
    [49]
    Blanchard A, Vargas-Poussou R, Vallet M, et al. Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome[J]. J Am Soc Nephrol, 2015, 26: 468-475. DOI: 10.1681/ASN.2014030293
    [50]
    Peng X, Jiang L, Chen C, et al. Increased urinary prostaglandin E2 metabolite: A potential therapeutic target of Gitelman syndrome[J]. PLoS One, 2017, 12: e0180811. DOI: 10.1371/journal.pone.0180811
    [51]
    Cho YJ, Park GT, Cho YJ, et al. Renal potassium wasting and hypocalciuria ameliorated with magnesium repletion in Gitelman's syndrome[J]. J Korean Med Sci, 1997, 12: 157-159. DOI: 10.3346/jkms.1997.12.2.157
    [52]
    Robinson CM, Karet Frankl FE. Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes[J]. Nephrol Dial Transplant, 2017, 32: 508-512. http://ndt.oxfordjournals.org/content/early/2016/03/02/ndt.gfw019.full.pdf
    [53]
    Hayashi M. Gitelman's syndrome and hypomagnesemia[J]. Intern Med, 2004, 43: 351-352. DOI: 10.2169/internalmedicine.43.351
    [54]
    Ayuk J, Gittoes NJ. How should hypomagnesaemia be investigated and treated?[J]. Clin Endocrinol (Oxf), 2011, 75: 743-746. DOI: 10.1111/j.1365-2265.2011.04092.x
    [55]
    Sundram V, Daly E, Waldron M. Gitelman syndrome: Case report of a toddler following salbutamol inhaler[J]. Archives of Disease in Childhood, 2019, 104: A182. DOI: 10.1136/archdischild-2019-epa.420
    [56]
    Tursi A. Gitelman syndrome triggered by proton-pump inhibitor use[J]. Dig Liver Dis, 2019, 51: 911. http://www.onacademic.com/detail/journal_1000042276219099_3327.html
    [57]
    Yuan T, Jiang L, Chen C, et al. Glucose tolerance and insulin responsiveness in Gitelman syndrome patients[J]. Endocr Connect, 2017, 6: 243-252. DOI: 10.1530/EC-17-0014
    [58]
    Blanchard A, Vallet M, Dubourg L, et al. Resistance to insulin in patients with Gitelman syndrome and a subtle intermediate phenotype in heterozygous carriers: a cross-sectional study[J]. J Am Soc Nephrol, 2019, 30: 1534-1545. DOI: 10.1681/ASN.2019010031
    [59]
    Ren H, Qin L, Wang W, et al. Abnormal glucose metabolism and insulin sensitivity in Chinese patients with Gitelman syndrome[J]. Am J Nephrol, 2013, 37: 152-157. DOI: 10.1159/000346708
    [60]
    Knoers NV, Levtchenko EN. Gitelman syndrome[J]. Orphanet J Rare Dis, 2008, 3: 22. DOI: 10.1186/1750-1172-3-22
    [61]
    Fujimura J, Nozu K, Yamamura T, et al. Clinical and Genetic Characteristics in Patients With Gitelman Syndrome[J]. Kidney Int Rep, 2018, 4: 119-125.
    [62]
    Cruz DN. The renal tubular Na-Cl co-transporter (NCCT): a potential genetic link between blood pressure and bone density?[J]. Nephrol Dial Transplant, 2001, 16: 691-694. http://ndt.oxfordjournals.org/content/16/4/691.2.full.pdf
    [63]
    Nicolet-Barousse L, Blanchard A, Roux C, et al. Inactivation of the Na-Cl co-transporter (NCC) gene is associated with high BMD through both renal and bone mechanisms: analysis of patients with Gitelman syndrome and Ncc null mice[J]. J Bone Miner Res, 2005, 20: 799-808. http://www.researchgate.net/profile/Anne_Blanchard2/publication/7911802_Inactivation_of_the_Na-Cl_co-transporter_%28NCC%29_gene_is_associated_with_high_BMD_through_both_renal_and_bone_mechanisms_analysis_of_patients_with_Gitelman_syndrome_and_Ncc_null_mice/links/5485a4190cf24356db6108f3.pdf
    [64]
    Gutierrez M, Silveri F, Bertolazzi C, et al. Gitelman syndrome, calcium pyrophosphate dihydrate deposition disease and crowned dens syndrome. A new association?[J]. Rheumatology (Oxford), 2010, 49: 610-613. DOI: 10.1093/rheumatology/kep324
    [65]
    Favero M, Calò LA, Schiavon F, et al. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases[J]. Best Pract Res Clin Rheumatol, 2011, 25: 637-648. DOI: 10.1016/j.berh.2011.10.013
    [66]
    Iqbal Z, Sayer JA. Chondrocalcinosis and Gitelman syndrome[J]. QJM, 2016, 109: 563-564. DOI: 10.1093/qjmed/hcw045
    [67]
    Viganò C, Amoruso C, Barretta F, et al. Renal phosphate handling in Gitelman syndrome-the results of a case-control study[J]. Pediatr Nephrol, 2013, 28: 65-70. DOI: 10.1007/s00467-012-2297-3
    [68]
    Bouchireb K, Boyer O, Mansour-Hendili L, et al. Fan-coni syndrome and severe polyuria: an uncommon clinicobiological presentation of a Gitelman syndrome[J]. BMC Pediatr, 2014, 14: 201. DOI: 10.1186/1471-2431-14-201
    [69]
    Balavoine AS, Bataille P, Vanhille P, et al. Phenotype-genotype correlation and follow-up in adult patients with hypokalaemia of renal origin suggesting Gitelman syndrome[J]. Eur J Endocrinol, 2011, 165: 665-673. DOI: 10.1530/EJE-11-0224
    [70]
    Zhou H, Liang X, Qing Y, et al. Complicated Gitelman syndrome and autoimmune thyroid disease: a case report with a new homozygous mutation in the SLC12A3 gene and literature review[J]. BMC Endocr Disord, 2018, 18: 82. DOI: 10.1186/s12902-018-0298-3
    [71]
    Miao Z, Gao Y, Bindels RJ, et al. Coexistence of normotensive primary aldosteronism in two patients with Gitelman's syndrome and novel thiazide-sensitive Na-Cl cotransporter mutations[J]. Eur J Endocrinol, 2009, 161: 275-283. DOI: 10.1530/EJE-09-0271
    [72]
    Mishima E, Mori T, Sohara E, et al. Inherited, not acquired, Gitelman syndrome in a patient with Sjögren's syndrome: importance of genetic testing to distinguish the two forms[J]. CEN Case Rep, 2017, 6: 180-184. DOI: 10.1007/s13730-017-0271-4
    [73]
    Elkoundi A, Kartite N, Bensghir M, et al. Gitelman syndrome: a rare life-threatening case of hypokalemic paralysis mimicking Guillain-Barré syndrome during pregnancy and review of the literature[J]. Clin Case Rep, 2017, 5: 1597-1603. DOI: 10.1002/ccr3.1122
    [74]
    Srinivas SK, Sukhan S, Elovitz MA. Nausea, emesis, and muscle weakness in a pregnant adolescent[J]. Obstet Gynecol, 2006, 107: 481-484. DOI: 10.1097/01.AOG.0000168450.72031.d4
    [75]
    Mascetti L, Bettinelli A, Simonetti GD, et al. Pregnancy in inherited hypokalemic salt-losing renal tubular disorder[J]. Obstet Gynecol, 2011, 117: 512-516. DOI: 10.1097/AOG.0b013e3182075317
    [76]
    Moustakakis MN, Bockorny M. Gitelman syndrome and pregnancy[J]. Clin Kidney J, 2012, 5: 552-555. DOI: 10.1093/ckj/sfs126
    [77]
    Gallagher H, Soar J, Tomson C. New guideline for perioperative management of people with inherited salt-wasting alkaloses[J]. Br J Anaesth, 2016, 116: 746-749. DOI: 10.1093/bja/aew102
    • Related Articles

  • Related Articles

    [1]XU Kexin, LI Guozhuang, WU Zhihong, ZHANG Jianguo, DISCO(Deciphering Disorders Involving Scoliosis & Comorbidities) Study Group, WU Nan. Progress in Clinical Diagnosis and Management of Short Stature in Ehlers-Danlos Syndromes[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 163-170. DOI: 10.12290/xhyxzz.2024-0173
    [2]ZHANG Ning, YANG Chenhao, ZHOU Liangrui, SUN Xiaohong, LIU Xiaohong, KANG Lin, LI Ji, LI Hailong. Cronkhite-Canada Syndrome Combined with Asymptomatic Novel Coronavirus Infection: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 406-412. DOI: 10.12290/xhyxzz.2023-0476
    [3]Chinese Society of Rare Diseases, Rare Diseases Society of Chinese Research Hospital Association, National Rare Diseases Committee, Beijing Rare Disease Diagnosis, Treatment and Protection Society. Expert Consensus for the Diagnosis and Treatment of Bartter Syndrome in China(2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 744-757. DOI: 10.12290/xhyxzz.2023-0207
    [4]ZHAO Zhe, TANG Yan, ZHOU Jingya, CHEN Xiaoguang, ZHANG Lei, CHEN Limeng, YUAN Tao. Analysis of Clinical Manifestations and Drug Therapies of Gitelman Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 277-286. DOI: 10.12290/xhyxzz.2021-0180
    [5]Acquired Immunodeficiency Syndrome and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention. Chinese Guidelines for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome(2021 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 203-226. DOI: 10.12290/xhyxzz.2022-0097
    [7]MAIMAITI Nu-rong-gu-li, Hua-bing ZHANG, Xiao-ping XING. Clinical and Genetic Analysis of a Uyghur Patient with Gitelman's Syndrome[J]. Medical Journal of Peking Union Medical College Hospital, 2015, 6(6): 427-431. DOI: 10.3969/j.issn.1674-9081.2015.06.006
    [8]Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006
    [9]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004
    [10]Zhi-lan MENG, Liang GAO, Jian-gang GU, Yu-feng LUO, Tao-ling ZHONG, Chen-yan ZHU. Application of Automatic DNA Image Cytometry in Diagnosis of Pleural Effusion[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(1): 36-40. DOI: 10.3969/j.issn.1674-9081.2012.01.009

  • Cited by

    Periodical cited type(28)

    1. 彭晓艳，陈朝英，涂娟，高洁，李华荣. 儿童肾小管酸中毒的临床特点及诊治. 中国医刊. 2025(01): 74-78 .
    2. 辛宇，徐俊杰，臧丽. Gitelman综合征导致糖代谢异常的相关因素分析. 中华糖尿病杂志. 2025(01): 153-161 .
    3. 张磊，乐偲，刘岩，陈丽萌. 遗传性罕见肾脏病：精准肾脏病学的窗口. 罕见病研究. 2024(01): 1-11 .
    4. 陈丽萌，陈朝英，张抒扬，张磊，彭晓艳，杨宏仙，简珊，樊晓红，蒋兰萍，董源，赵若环，吕宁，乐偲，涂娟. Bartter综合征诊疗中国专家共识(2023). 罕见病研究. 2024(01): 87-101 .
    5. 周冬祺，唐诗韵，陈秋. SLC12A3基因新型纯合突变导致的Gitelman综合征合并2型糖尿病家系追踪. 中华糖尿病杂志. 2024(02): 248-253 .
    6. 陈蓉，王曦，宋桉，王佳佳，李伟，陈适，邢小平. 青年女性，乏力，低血钾，高血糖. 协和医学杂志. 2024(02): 456-461 . 本站查看
    7. 张洪旭，李娟娟，程炳菲，辛颖. Gitelman综合征合并库欣病1例并文献复习. 临床肾脏病杂志. 2024(04): 349-352 .
    8. 何敏，吴加华，刘剑，赵延栋，王云卿，吴君平. Gitelman综合征合并下颌肿物1例并文献复习. 中国乡村医药. 2024(11): 51-52 .
    9. 马韩铮，杨玲玲，刘栋，李岩. 扶阳建中针刺法治疗以矮身材为主要表现的Gitelman综合征1例. 中医儿科杂志. 2024(04): 89-91 .
    10. 葛丹，胡雪剑. Gitelman综合征合并抑郁症1例. 中国医药科学. 2024(16): 188-190 .
    11. 林彦琳，毕丽妨，王珏. 单等位 SLC12A3基因突变致Gitelman综合征1例的遗传学分析. 国际遗传学杂志. 2024(05): 361-365 .
    12. 周奇，李沁原，刘雅莉，罗征秀，张卫社，陈彤，李国保，商洪才，杨克虎，张波，陈耀龙，张抒扬. 罕见病指南的制订：现状、挑战与机遇. 协和医学杂志. 2023(03): 621-628 . 本站查看
    13. 穆妮热·阿塔吾拉，郭艳英. Gitelman综合征并发症及常见合并症的研究进展. 医学研究杂志. 2023(05): 177-179+114 .
    14. 陈杰梅，郑跃杰，高晓洁，南晓娟. 儿童Gitelman综合征的临床特征、基因型及预后分析. 国际医药卫生导报. 2023(13): 1850-1856 .
    15. 朱惠娟，卢琳，张晓波，吕晓虹，张丁月，陈适. 双侧岩下窦静脉采血在库欣综合征诊断中应用的专家共识(2023). 罕见病研究. 2023(03): 365-376 .
    16. 穆妮热·阿塔吾拉，马福慧，张凯迪，王新玲，郭艳英. 2011-2020年新疆某三甲医院低钾血症病因构成及血钾特点分析. 新疆医学. 2023(06): 639-642+669 .
    17. 阚路兰，田茂强，唐一蜜. 以腹痛为首发症状的轻型Gitelman综合征患儿1例及文献复习. 中华妇幼临床医学杂志(电子版). 2023(04): 473-479 .
    18. 李雪峰，韩宾宾，王善龙，姜卫波，彭慧芳，姜宏卫. 不同伴随症的Gitelman综合征的诊治研究. 临床医学. 2023(11): 1-4 .
    19. 阮希成，朱荣杰，蔡奕琪，郑浩，林程，陈宏斌. 妊娠合并Gitelman综合征1例. 福建医科大学学报. 2023(05): 380-382 .
    20. 李文文，鲁瑾. Gitelman综合征伴胰岛素抵抗1例. 中华糖尿病杂志. 2023(Z1): 96-98 .
    21. 陈甜甜，王晓东，余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习. 中华妇幼临床医学杂志(电子版). 2023(05): 559-568 .
    22. 赵喆，唐彦，周婧雅，陈晓光，张磊，陈丽萌，袁涛. 50例Gitelman综合征患者临床特征和药物治疗分析. 协和医学杂志. 2022(02): 277-286 . 本站查看
    23. 谢容融，金萍，杨幼波，张勤，熊静. 全外显子组测序诊断2例Gitelman综合征. 中南大学学报(医学版). 2022(03): 401-406 .
    24. 陈正，吴娟，邱瑜，刘建萍. Gitelman综合征伴2型糖尿病一例报道. 中国糖尿病杂志. 2022(05): 370-374 .
    25. 李敏，黄稳莹，张甜，郭英. 1例Gitelman综合征合并亚临床甲状腺功能减退症患者SLC12A3基因突变位点鉴定及遗传分析. 山东医药. 2022(15): 86-89 .
    26. 朱凯瑞，李霞，李晓岚. 从1例Gitelman综合征探讨低钾血症的全科诊疗思路. 巴楚医学. 2022(02): 14-17 .
    27. 甘佳乐，刘超，方亮娟. SLC12A3基因突变致Gitelman综合征1例. 国际遗传学杂志. 2022(06): 499-502 .
    28. 仝天，王瑞英，张力辉，刘志红，骆建芹，赵占胜. 血镁正常的Gitelman综合征1例及文献复习. 临床荟萃. 2022(11): 1031-1036 .

    Other cited types(4)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (2516) PDF downloads (846) Cited by(32)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close